Stay updated on Avelumab First-line NSCLC Clinical Trial
Sign up to get notified when there's something new on the Avelumab First-line NSCLC Clinical Trial page.

Latest updates to the Avelumab First-line NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRecord history now shows 'No longer looking for participants,' indicating recruitment for the study has ended. It also shows a version update to Revision: v3.6.0 and the removal of Revision: v3.5.5.SummaryDifference0.2%

- Check21 days agoChange DetectedThe history section now shows Revision: v3.5.5 instead of Revision: v3.5.4, indicating an update to the record's revision status rather than substantive content changes.SummaryDifference0.1%

- Check42 days agoChange DetectedThe revision history adds a new Revision: v3.5.4 entry, updating the page's version lineage by replacing the previous v3.5.3 entry.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry, v3.5.3, has been added to the study's record history, representing an updated version of the record. The previous revision, v3.5.2, has been removed from the history.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page history now shows revision v3.5.2, replacing the previous v3.5.0. This is a minor metadata update and does not change study data, eligibility, or user-facing content.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision entry v3.5.0 was added and the previous revision v3.4.3 was removed from the record history.SummaryDifference0.1%

Stay in the know with updates to Avelumab First-line NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab First-line NSCLC Clinical Trial page.